A Comparative Study Between ABP 501 and Humira ® in Participants With Moderate to Severe Plaque Psoriasis
Condition:   Plaque Psoriasis Interventions:   Drug: Adalimumab;   Drug: ABP 501 Sponsor:   Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials

A Comparative Study Between ABP 501 and Humira ® in Participants With Moderate to Severe Plaque Psoriasis
Condition:   Plaque Psoriasis Interventions:   Drug: Adalimumab;   Drug: ABP 501 Sponsor:   Amgen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials